Filing Details

Accession Number:
0001093557-21-000172
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-24 17:59:50
Reporting Period:
2021-06-22
Accepted Time:
2021-06-24 17:59:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1093557 Dexcom Inc DXCM Surgical & Medical Instruments & Apparatus (3841) 330857544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236386 S Jay Skyler 6340 Sequence Drive
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-22 6,264 $425.45 27,704 No 4 S Indirect by Partnership
Common Stock Disposition 2021-06-22 8,334 $426.56 19,370 No 4 S Indirect by Partnership
Common Stock Disposition 2021-06-22 5,402 $427.14 13,968 No 4 S Indirect by Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Partnership
No 4 S Indirect by Partnership
No 4 S Indirect by Partnership
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 900 Direct
Common Stock 10,000 Indirect by Spouse
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 7, 2020, and amended effective February 17, 2021. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Skyler.
  2. This transaction was executed in multiple trades at prices ranging from $425.00 to $425.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. Shares are held by Skyler Bach Family Limited Partnership, LLP, with respect to which the reporting person is a managing partner of the partnership and maintains voting rights of these shares.
  4. This transaction was executed in multiple trades at prices ranging from $426.00 to $426.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
  5. This transaction was executed in multiple trades at prices ranging from $427.000 to $427.455. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  6. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.